vs
Side-by-side financial comparison of Mind Medicine (MindMed) Inc. (DFTX) and Reborn Coffee, Inc. (REBN). Click either name above to swap in a different company.
Reborn Coffee, Inc. is the larger business by last-quarter revenue ($1.4M vs $906.0K, roughly 1.5× Mind Medicine (MindMed) Inc.). Reborn Coffee, Inc. runs the higher net margin — -254.3% vs -2634.0%, a 2379.7% gap on every dollar of revenue. On growth, Reborn Coffee, Inc. posted the faster year-over-year revenue change (7.8% vs -16.1%).
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
Reborn Coffee, Inc. is a specialty coffee roaster and retailer that offers premium single-origin and blended roasted coffee beans, handcrafted espresso drinks, baked snacks and related merchandise. It operates brick-and-mortar cafe locations primarily across the United States, alongside direct-to-consumer online sales and wholesale distribution to foodservice partners, with a core focus on ethically sourced, high-quality coffee products.
DFTX vs REBN — Head-to-Head
Income Statement — Q4 FY2023 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $906.0K | $1.4M |
| Net Profit | $-23.9M | $-3.4M |
| Gross Margin | — | — |
| Operating Margin | -2450.8% | -224.7% |
| Net Margin | -2634.0% | -254.3% |
| Revenue YoY | -16.1% | 7.8% |
| Net Profit YoY | -386.7% | -379.3% |
| EPS (diluted) | $-0.58 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $1.4M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $1.8M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $1.5M | ||
| Q4 23 | $906.0K | $1.4M |
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $-5.3M | ||
| Q1 25 | — | $-2.2M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | — | $-719.7K | ||
| Q2 24 | — | $-1.3M | ||
| Q1 24 | — | $-990.5K | ||
| Q4 23 | $-23.9M | $-1.7M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 98.7% | ||
| Q4 23 | — | 94.3% |
| Q3 25 | — | -224.7% | ||
| Q2 25 | — | -240.2% | ||
| Q1 25 | — | -100.2% | ||
| Q4 24 | — | -95.2% | ||
| Q3 24 | — | -57.6% | ||
| Q2 24 | — | -97.4% | ||
| Q1 24 | — | -56.9% | ||
| Q4 23 | -2450.8% | -122.6% |
| Q3 25 | — | -254.3% | ||
| Q2 25 | — | -291.0% | ||
| Q1 25 | — | -129.4% | ||
| Q4 24 | — | -100.0% | ||
| Q3 24 | — | -57.2% | ||
| Q2 24 | — | -95.9% | ||
| Q1 24 | — | -65.3% | ||
| Q4 23 | -2634.0% | -127.0% |
| Q3 25 | — | $-0.68 | ||
| Q2 25 | — | $-1.15 | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $-0.28 | ||
| Q3 24 | — | $-0.30 | ||
| Q2 24 | — | $-0.48 | ||
| Q1 24 | — | $-0.60 | ||
| Q4 23 | $-0.58 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.7M | $44.0K |
| Total DebtLower is stronger | — | $500.0K |
| Stockholders' EquityBook value | $78.1M | $-3.4M |
| Total Assets | $124.5M | $6.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $44.0K | ||
| Q2 25 | — | $77.9K | ||
| Q1 25 | — | $777.1K | ||
| Q4 24 | — | $158.2K | ||
| Q3 24 | — | $105.9K | ||
| Q2 24 | — | $617.1K | ||
| Q1 24 | — | $70.3K | ||
| Q4 23 | $99.7M | $164.3K |
| Q3 25 | — | $500.0K | ||
| Q2 25 | — | $500.0K | ||
| Q1 25 | — | $500.0K | ||
| Q4 24 | — | $500.0K | ||
| Q3 24 | — | $500.0K | ||
| Q2 24 | — | $500.0K | ||
| Q1 24 | — | $500.0K | ||
| Q4 23 | — | $500.0K |
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $-1.9M | ||
| Q1 25 | — | $415.6K | ||
| Q4 24 | — | $2.6M | ||
| Q3 24 | — | $2.7M | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $2.6M | ||
| Q4 23 | $78.1M | $846.4K |
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $6.4M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $7.8M | ||
| Q3 24 | — | $9.6M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | — | $10.9M | ||
| Q4 23 | $124.5M | $9.3M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.19× | ||
| Q4 23 | — | 0.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-20.6M | $-1.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | $-3.6M | ||
| Q1 25 | — | $464.6K | ||
| Q4 24 | — | $-132.6K | ||
| Q3 24 | — | $-424.0K | ||
| Q2 24 | — | $-961.8K | ||
| Q1 24 | — | $-1.9M | ||
| Q4 23 | $-20.6M | $-188.2K |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-600.9K | ||
| Q3 24 | — | $-424.0K | ||
| Q2 24 | — | $-1.3M | ||
| Q1 24 | — | $-2.9M | ||
| Q4 23 | — | $-1.9M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -33.8% | ||
| Q3 24 | — | -33.7% | ||
| Q2 24 | — | -95.3% | ||
| Q1 24 | — | -192.4% | ||
| Q4 23 | — | -137.1% |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 25.2% | ||
| Q1 24 | — | 65.0% | ||
| Q4 23 | — | 123.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFTX
Segment breakdown not available.
REBN
| Stores | $1.1M | 83% |
| Other | $229.9K | 17% |
